A recent publication from Dr Xuesen Dong and team is featured as...
The Vancouver Prostate Centre is pleased to announce the appointment of Don Mattrick to our Board of Directors.
Don is currently is co-founder and co-president of MdGB Capital, a private company that manages a group assets and operating companies throughout North America.
The UBC Faculty of Medicine today published "Translating research to treat prostate cancer" - a profile of the translational research breakthroughs being made at our Centre. Featuring our Executive Director Dr. Gleave, the article discusses the innovative potential therapeutics discovered by Drs. Rennie, Cherkasov and Zoubeidi.
February 25, 2019 - Scientists at the University of British Columbia have discovered a new protein “switch” that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Dr. Amina Zoubeidi was featured in articles on VCHRI News and Prostate Cancer Canada on February 11, 2019, the International Day of Women and Girls in Science.
The VCHRI News article, "Ask an expert: Who runs the (science) world?" contains interviews with three researchers at VCHRI who share their experiences and offer advice for the next generation of women scientists.
Dr YZ Wang and his co-applicants Drs Ci, He and Lin were the recipients of a five-year CIHR Project Grant (Fall 2018 competition) for their proposal titled "Function and therapeutic potential of SUV420H2 in neuroendocrine prostate cancer."
Three VPC trainees received Prostate Cancer Foundation BC research grants:
Gillian Vandekerkhove, a PhD student working under the supervision of Dr. Alexander Wyatt, is co-first author on two papers published in European Urology (Impact Factor 17.5) this month:
January's Prostate Cancer Canada blog features an interview with Dr. Paul Rennie titled From idea to possibility: Moving research from the lab to patient care.
The Society of Urologic Oncology (SUO) awarded the 2018 Huggins Medal to Dr. Martin Gleave. The medal is presented in recognition by the SUO of a major contribution and/or lifetime achievement in research and/or clinical practice that has contributed to the progress in the treatment for patients with genitourinary neoplasms. It has been awarded annually since 2001.
Dr. Amina Zoubeidi's project, Reversing Neuroendocrine Prostate Cancer (NEPC), was rated as one of the Top 5 Research Stories at The 25th Annual Prostate Cancer Foundation Scientific Retreat, held October 26- 28, at the La Costa Resort in Carlsbad, CA.
The Prostate Cancer Foundation's Science Department rated the topics or discoveries discussed during the Scientific Retreat, and described each of the top five on their website. For Dr. Zoubeidi, the description is: